HB920 — INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)
Last action — Read by title, under the rules, referred to the Committee on Insurance.
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the House. Introduced February 27, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Introduced
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 D).
-
Cleared a recorded vote
Passed 1 recorded vote so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)
Bill Text
We don't have the full text on file for this bill yet.
Read HB920 on the official Louisiana source →Action History
-
Prefiled.
-
Under the rules, provisionally referred to the Committee on Insurance.
-
First appeared in the Interim Calendar on 2/27/2026.
-
Read by title, under the rules, referred to the Committee on Insurance.
Sponsors
- Edmond Jordan · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 146 not signed on
Sponsors (1)
- Edmond Jordan Democrat
Co-sponsors (0)
None.
Not signed on (146)
146 members have not signed on to this bill.
Show all 146 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Republican | 7 | 0 | 0 | 0 |
| Democrat | 5 | 0 | 0 | 0 |
| Total | 12 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (12)
| Member | Party | Vote |
|---|---|---|
| Ed Murray | Democrat | Yea |
| Edmond Jordan | Democrat | Yea |
| Jr., Kyle M. Green | Democrat | Yea |
| Shaun Raphael Mena | Democrat | Yea |
| Tammy T. Phelps | Democrat | Yea |
| Brian Leonard Glorioso | Republican | Yea |
| III, Roger William Wilder | Republican | Yea |
| Jr., Dennis Bamburg | Republican | Yea |
| Jr., Jack "Jay" William Gallé | Republican | Yea |
| Jr., John R. Illg | Republican | Yea |
| Michael "Gabe" Firment | Republican | Yea |
| Troy Jude Hebert | Republican | Yea |
Subjects
Frequently asked questions
- What does HB920 do?
- INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)
- Who sponsors HB920?
- HB920 is sponsored by Edmond Jordan (Democrat).
- What is the current status of HB920?
- This bill has been introduced in the House. Introduced February 27, 2026. It must pass committee before a floor vote.
- Where can I track HB920?
- Track HB920 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB920
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB920
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →